Lysle Johnston's observations, as ever, give plenty of food for thought, and as Lysle (see this issue) has done more than anyone in North America to challenge the irrational dogma and of much of the American orthodontic industry, he knows whereof he speaks. He rightly points out that some questions are more important than others and that our energies should be conserved for the more important ones. And I agree that for a limited number of questions we must respect alternative research methodologies to the randomised trial. One would certainly like to see utility analysis used much more for comparisons of dissimilar interventions in dentistry, such as orthognathic surgery versus orthodontics.
But why is the randomised clinical trial, in Lysle's words, so`exalted'? Is this really just intellectual snobbery? As someone who has done as much as anyone to muddy the waters of clinical science through uncontrolled retrospective studies, some of them worryingly large, I might be tempted to agree. However, by dint of my involvement in the Cochrane Collaboration, my worse fears of the influence of bias in research have sadly been confirmed. There is now a vast amount of empirical research, some of it quite old, to show that non-controlled studies are much more likely to reach a distorted or inflated view of effectiveness. For instance, one review of 52 published uncontrolled trials in psychiatry found that 85% of them reported therapeutic success, whereas, in 20 published trials with a control group, only 25% reported therapeutic success. 1 Similarly, a review of 53 studies of portacavel shunt operation for portal hypertension found that, of 32 uncontrolled studies, 75% were markedly enthusiastic, whereas 6 controlled trials found little or no support. 2 And, in one comparison of a series of historical control studies, the new treatment was found to be superior in 79% of studies. With randomisation, the figure fell to 20%. 3 The pervasive effect of bias can even distort randomised trials where the randomisation arrangements are not fully concealed. 4 Undoubtedly uncontrolled orthodontic research is just as flawed, but is it realistic to replace it with randomised trials? The answer, I believe, is undoubtedly`yes', though it may be more easy in some places than others. In the US, funds were provided in the mid-nineties by the National Institute for Dental Research for studies of the treatment of Class II malocclusion and results have begun to emerge from three randomised trials initiated at academic centres.
5±7 These studies will probably be criticised, however, as they may not represent the real world. But orthodontics in the US is a commodity largely delivered by small businesses, often in mutual competition, which makes it difficult to achieve the co-operation necessary to generate adequate samples in everyday practice. Sadly it is hard to see this situation change unless the inadequacy of current knowledge is acknowledged by its practitioners and explained to its consumers. On the other hand, a large proportion of orthodontic care, mainly for complex malocclusion, is provided in the UK by a network of NHS consultant units. Twelve of those units are currently cooperating in two concurrent randomised trials of Class II treatment led by Kevin O'Brien and with full ethical consent 400 patients have been enrolled in treatment, (at a fraction of the cost of the US trials). One can easily envisage similar networks of British general dental practitioners, perhaps under the auspices of the Faculties of Dental Surgery at the Royal Colleges, collaborating on randomised trials to address a host of important tasks undertaken each day in dentistry. Again the crucial starting point for such initiatives will be the forthright acknowledgement that our current knowledge just isn't reliable.
If I disagree with Lysle Johnston, it is in our differing level of optimism for the range and complexity of trials that we will be able to do, with full ethical consent of patients. In a current multicentre trial of primary cleft lip and palate surgery in the UK and Scandinavia, coordinated by Gunvor Semb, 96% of parents have elected to have their children participate. And we can Evidence-Based Dentistry (2000) 2, 7 ± 8 ã 2000 Evidence-Based Dentistry All rights reserved 1462-0049/00 $15.00 www.nature.com/ebd take heart from other disciplines that have overcome the challenges involved in mounting trials of surgery versus conservative treatment, or treatment versus no treatment for a range of conditions. 8±14 Jayne Harrison's systematic review of crossbite was inevitably constrained by the desultory quality of research that typifies orthodontics today. But she is young enough to be confident that her hard won skills will come in useful for future systematic reviews of better orthodontic research. I wish the same could be said for Lysle and me.
